Nvidia denies rumours it will cut supplies to China-February 2024-www.financetom.com

Nvidia denies rumours it will cut supplies to China

News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities

Nvidia denies rumours it will cut supplies to China

Dec 12, 2024 3:33 AM

BEIJING, Dec 12 (Reuters) - Nvidia ( NVDA ) said recent

social media posts alleging the company would cut supplies to

China were false, according to a company post on Chinese social

media.

Nvidia ( NVDA ) said that China was an important market and it would

continue to provide high-quality products and services to

Chinese customers.

Previous page： Market Chatter: American Airlines Reportedly Attempting to Delay Resumption of 2 China Flights Next page： US House votes narrowly to repeal Biden administration EPA tailpipe emissions rules

Comments

Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.

Show More Comments

Related Articles >

Market Chatter: American Airlines Reportedly Attempting to Delay Resumption of 2 China Flights

Sep 21, 2024

12:03 PM EDT, 09/20/2024 (MT Newswires) -- American Airlines Group ( AAL ) is seeking to delay the resumption of two daily flights from the US to China due to sluggish demand, Reuters reported Friday. American Airlines ( AAL ) has requested the US Transportation Department's approval to extend a waiver to continue the suspension of the daily flights to...

US House votes narrowly to repeal Biden administration EPA tailpipe emissions rules

Sep 21, 2024

WASHINGTON (Reuters) - The U.S. House of Representatives on Friday voted narrowly to repeal clean vehicle rules adopted in March to cut fleetwide tailpipe emissions by 50% over 2026 levels by 2032. House Republicans said the Environmental Protection Agency's final regulation would effectively push gas-powered vehicles out of the U.S. marketplace. The White House on Friday said President Joe Biden...

Novo Nordisk Stock Declines After Headline Results From Mid-Stage Study Of Monlunabant In Obese Patients

Sep 21, 2024

Friday, Novo Nordisk A/S ( NVO ) announced headline results from a phase 2a clinical trial with monlunabant, a small-molecule oral cannabinoid receptor 1 (CB1) inverse agonist. Monlunabant, formerly INV-202, was part of the acquisition of Inversago Pharmaceuticals Inc. for $1.075 billion, announced in August 2023. Also Read: European Drug Agency Supports Novo Nordisk’s Blockbuster Weight-Loss Drug Wegovy For Obesity-Related...

--FTC Sues PBMs of CVS, Cigna, UnitedHealth for Allegedly Inflating Insulin Prices

Sep 21, 2024

12:07 PM EDT, 09/20/2024 (MT Newswires) -- Price: 57.44, Change: -0.96, Percent Change: -1.65 ...